Cargando…

Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients

PURPOSE: [(18)F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) parameters have shown prognostic value in nasopharyngeal carcinomas (NPC), mostly in monocenter studies. The aim of this study was to assess the prognostic impact of standard and novel PET parameters in a multicenter cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Zschaeck, Sebastian, Li, Yimin, Lin, Qin, Beck, Marcus, Amthauer, Holger, Bauersachs, Laura, Hajiyianni, Marina, Rogasch, Julian, Ehrhardt, Vincent H., Kalinauskaite, Goda, Weingärtner, Julian, Hartmann, Vivian, van den Hoff, Jörg, Budach, Volker, Stromberger, Carmen, Hofheinz, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392321/
https://www.ncbi.nlm.nih.gov/pubmed/32730364
http://dx.doi.org/10.1371/journal.pone.0236841
_version_ 1783564824869863424
author Zschaeck, Sebastian
Li, Yimin
Lin, Qin
Beck, Marcus
Amthauer, Holger
Bauersachs, Laura
Hajiyianni, Marina
Rogasch, Julian
Ehrhardt, Vincent H.
Kalinauskaite, Goda
Weingärtner, Julian
Hartmann, Vivian
van den Hoff, Jörg
Budach, Volker
Stromberger, Carmen
Hofheinz, Frank
author_facet Zschaeck, Sebastian
Li, Yimin
Lin, Qin
Beck, Marcus
Amthauer, Holger
Bauersachs, Laura
Hajiyianni, Marina
Rogasch, Julian
Ehrhardt, Vincent H.
Kalinauskaite, Goda
Weingärtner, Julian
Hartmann, Vivian
van den Hoff, Jörg
Budach, Volker
Stromberger, Carmen
Hofheinz, Frank
author_sort Zschaeck, Sebastian
collection PubMed
description PURPOSE: [(18)F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) parameters have shown prognostic value in nasopharyngeal carcinomas (NPC), mostly in monocenter studies. The aim of this study was to assess the prognostic impact of standard and novel PET parameters in a multicenter cohort of patients. METHODS: The established PET parameters metabolic tumor volume (MTV), total lesion glycolysis (TLG) and maximal standardized uptake value (SUV(max)) as well as the novel parameter tumor asphericity (ASP) were evaluated in a retrospective multicenter cohort of 114 NPC patients with FDG-PET staging, treated with (chemo)radiation at 8 international institutions. Uni- and multivariable Cox regression and Kaplan-Meier analysis with respect to overall survival (OS), event-free survival (EFS), distant metastases-free survival (FFDM), and locoregional control (LRC) was performed for clinical and PET parameters. RESULTS: When analyzing metric PET parameters, ASP showed a significant association with EFS (p = 0.035) and a trend for OS (p = 0.058). MTV was significantly associated with EFS (p = 0.026), OS (p = 0.008) and LRC (p = 0.012) and TLG with LRC (p = 0.019). TLG and MTV showed a very high correlation (Spearman’s rho = 0.95), therefore TLG was subesequently not further analysed. Optimal cutoff values for defining high and low risk groups were determined by maximization of the p-value in univariate Cox regression considering all possible cutoff values. Generation of stable cutoff values was feasible for MTV (p<0.001), ASP (p = 0.023) and combination of both (MTV+ASP = occurrence of one or both risk factors, p<0.001) for OS and for MTV regarding the endpoints OS (p<0.001) and LRC (p<0.001). In multivariable Cox (age >55 years + one binarized PET parameter), MTV >11.1ml (hazard ratio (HR): 3.57, p<0.001) and ASP > 14.4% (HR: 3.2, p = 0.031) remained prognostic for OS. MTV additionally remained prognostic for LRC (HR: 4.86 p<0.001) and EFS (HR: 2.51 p = 0.004). Bootstrapping analyses showed that a combination of high MTV and ASP improved prognostic value for OS compared to each single variable significantly (p = 0.005 and p = 0.04, respectively). When using the cohort from China (n = 57 patients) for establishment of prognostic parameters and all other patients for validation (n = 57 patients), MTV could be successfully validated as prognostic parameter regarding OS, EFS and LRC (all p-values <0.05 for both cohorts). CONCLUSIONS: In this analysis, PET parameters were associated with outcome of NPC patients. MTV showed a robust association with OS, EFS and LRC. Our data suggest that combination of MTV and ASP may potentially further improve the risk stratification of NPC patients.
format Online
Article
Text
id pubmed-7392321
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-73923212020-08-05 Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients Zschaeck, Sebastian Li, Yimin Lin, Qin Beck, Marcus Amthauer, Holger Bauersachs, Laura Hajiyianni, Marina Rogasch, Julian Ehrhardt, Vincent H. Kalinauskaite, Goda Weingärtner, Julian Hartmann, Vivian van den Hoff, Jörg Budach, Volker Stromberger, Carmen Hofheinz, Frank PLoS One Research Article PURPOSE: [(18)F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) parameters have shown prognostic value in nasopharyngeal carcinomas (NPC), mostly in monocenter studies. The aim of this study was to assess the prognostic impact of standard and novel PET parameters in a multicenter cohort of patients. METHODS: The established PET parameters metabolic tumor volume (MTV), total lesion glycolysis (TLG) and maximal standardized uptake value (SUV(max)) as well as the novel parameter tumor asphericity (ASP) were evaluated in a retrospective multicenter cohort of 114 NPC patients with FDG-PET staging, treated with (chemo)radiation at 8 international institutions. Uni- and multivariable Cox regression and Kaplan-Meier analysis with respect to overall survival (OS), event-free survival (EFS), distant metastases-free survival (FFDM), and locoregional control (LRC) was performed for clinical and PET parameters. RESULTS: When analyzing metric PET parameters, ASP showed a significant association with EFS (p = 0.035) and a trend for OS (p = 0.058). MTV was significantly associated with EFS (p = 0.026), OS (p = 0.008) and LRC (p = 0.012) and TLG with LRC (p = 0.019). TLG and MTV showed a very high correlation (Spearman’s rho = 0.95), therefore TLG was subesequently not further analysed. Optimal cutoff values for defining high and low risk groups were determined by maximization of the p-value in univariate Cox regression considering all possible cutoff values. Generation of stable cutoff values was feasible for MTV (p<0.001), ASP (p = 0.023) and combination of both (MTV+ASP = occurrence of one or both risk factors, p<0.001) for OS and for MTV regarding the endpoints OS (p<0.001) and LRC (p<0.001). In multivariable Cox (age >55 years + one binarized PET parameter), MTV >11.1ml (hazard ratio (HR): 3.57, p<0.001) and ASP > 14.4% (HR: 3.2, p = 0.031) remained prognostic for OS. MTV additionally remained prognostic for LRC (HR: 4.86 p<0.001) and EFS (HR: 2.51 p = 0.004). Bootstrapping analyses showed that a combination of high MTV and ASP improved prognostic value for OS compared to each single variable significantly (p = 0.005 and p = 0.04, respectively). When using the cohort from China (n = 57 patients) for establishment of prognostic parameters and all other patients for validation (n = 57 patients), MTV could be successfully validated as prognostic parameter regarding OS, EFS and LRC (all p-values <0.05 for both cohorts). CONCLUSIONS: In this analysis, PET parameters were associated with outcome of NPC patients. MTV showed a robust association with OS, EFS and LRC. Our data suggest that combination of MTV and ASP may potentially further improve the risk stratification of NPC patients. Public Library of Science 2020-07-30 /pmc/articles/PMC7392321/ /pubmed/32730364 http://dx.doi.org/10.1371/journal.pone.0236841 Text en © 2020 Zschaeck et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Zschaeck, Sebastian
Li, Yimin
Lin, Qin
Beck, Marcus
Amthauer, Holger
Bauersachs, Laura
Hajiyianni, Marina
Rogasch, Julian
Ehrhardt, Vincent H.
Kalinauskaite, Goda
Weingärtner, Julian
Hartmann, Vivian
van den Hoff, Jörg
Budach, Volker
Stromberger, Carmen
Hofheinz, Frank
Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients
title Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients
title_full Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients
title_fullStr Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients
title_full_unstemmed Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients
title_short Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients
title_sort prognostic value of baseline [(18)f]-fluorodeoxyglucose positron emission tomography parameters mtv, tlg and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392321/
https://www.ncbi.nlm.nih.gov/pubmed/32730364
http://dx.doi.org/10.1371/journal.pone.0236841
work_keys_str_mv AT zschaecksebastian prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT liyimin prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT linqin prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT beckmarcus prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT amthauerholger prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT bauersachslaura prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT hajiyiannimarina prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT rogaschjulian prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT ehrhardtvincenth prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT kalinauskaitegoda prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT weingartnerjulian prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT hartmannvivian prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT vandenhoffjorg prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT budachvolker prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT strombergercarmen prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients
AT hofheinzfrank prognosticvalueofbaseline18ffluorodeoxyglucosepositronemissiontomographyparametersmtvtlgandasphericityinaninternationalmulticentercohortofnasopharyngealcarcinomapatients